Efficacy of Tailored Bowel Preparation Strategy Guided by a Predictive Model
1 other identifier
interventional
429
1 country
1
Brief Summary
About 30% of patients were reported to suffer inadequate bowel preparation. So, it is desirable to prescribe personalized regimen according to patient's personal characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 3, 2017
CompletedFirst Posted
Study publicly available on registry
May 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2017
CompletedSeptember 11, 2017
September 1, 2017
3 months
May 3, 2017
September 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
adequate bowel preparation rates between 2 groups.
adequate bowel preparation rates between 2 groups according to Boston Bowel Preparation Scale (BBPS)
4 months
Study Arms (2)
Group A: standard group
ACTIVE COMPARATORParticipants are given standard regimen: 2 L Polyethylene Glycol (PEG) regimen.
Group B: tailored group
EXPERIMENTALParticipants are given personalized regimens for bowel preparation according to the the predictive model( a model which grades patients as low or high risk according to risk factors such as age, body mass index≧ 30 kg/m2, diabetes, constipation, pelvic surgery and tricyclic antidepressants usage). Low risk patients are given standard regimen: 2 L Polyethylene Glycol (PEG) regimen; High risk patients are given standard regimen: 4 L Polyethylene Glycol (PEG) regimen.
Interventions
participants in Group A and Low risk patients in group B are given standard regimen: 2 L Polyethylene Glycol (PEG) regimen.
Eligibility Criteria
You may qualify if:
- patients aged 18 or older
- patients undergoing colonoscopy
You may not qualify if:
- patients with a history of colorectal surgery
- patients with severe colonic stricture or obstructing tumor
- patients with dysphagia
- patients with compromised swallowing reflex or mental status
- patients with significant gastroparesis or gastric outlet obstruction
- patients with known or suspected bowel obstruction or perforation
- patients with severe chronic renal failure (creatinine clearance\<30 ml/min)
- patients with severe chronic renal failure (creatinine clearance\<30 ml/min)
- patients with uncontrolled hypertension (systolic blood pressure\>170 mm Hg, diastolic blood pressure\>100 mm Hg)
- patients with inflammatory bowel disease or megacolon
- patients with dehydration
- patients with dehydration
- patients with pregnancy or lactation
- patients hemodynamically unstable
- patients unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastroenterology, Qilu Hospital, Shandong University
Ji'nan, Shandong, 250012, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Li Yanqing, PhD,MD
Qilu Hospital of Shandong University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice president of Qilu Hospital
Study Record Dates
First Submitted
May 3, 2017
First Posted
May 8, 2017
Study Start
May 1, 2017
Primary Completion
July 30, 2017
Study Completion
August 30, 2017
Last Updated
September 11, 2017
Record last verified: 2017-09